Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Mesothelioma & Rare Thoracic

Dean Fennell

迪恩·芬内尔

PhD, FRCP

🏢University of Leicester(莱斯特大学)🌐UK

Professor of Thoracic Medical Oncology and Chair of Thoracic Oncology胸部肿瘤内科学教授兼胸部肿瘤学主席

48
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Dean Fennell leads mesothelioma research at the University of Leicester and is a principal investigator for the UK MesobanK tissue biobank. He focuses on molecular drivers of mesothelioma, BAP1 tumor suppressor biology, and novel therapeutic targeting, leading major UK and European clinical trials.

Share:

🧪Research Fields 研究领域

Mesothelioma间皮瘤
Molecular Biology分子生物学
Apoptosis Research细胞凋亡研究

🎓Key Contributions 主要贡献

Molecular Pathogenesis

Elucidated the role of BAP1, NF2, and SETD2 mutations in mesothelioma oncogenesis, providing the molecular framework for targeted therapy development.

MesobanK Biobank

Co-founded and directs the UK MesobanK, the world's largest mesothelioma tissue biobank, enabling translational research and biomarker discovery at scale.

Novel Therapeutics

Led CONFIRM and RAMES trials of nivolumab and ramucirumab in relapsed mesothelioma, demonstrating clinically meaningful benefit and informing second-line treatment standards.

Representative Works 代表性著作

[1]

Nivolumab versus placebo in previously treated malignant pleural mesothelioma (CONFIRM)

Lancet Oncology (2021)

Phase III trial establishing nivolumab as the first immunotherapy with a significant overall survival benefit in relapsed mesothelioma.

[2]

Whole-exome sequencing of mesothelioma reveals frequent mutations in the BAP1 and NF2 genes

Nature Genetics (2011)

Landmark genomic analysis defining the mutational landscape of mesothelioma and identifying key therapeutic targets.

[3]

Navitoclax combined with pemetrexed and cisplatin in patients with advanced mesothelioma

Journal of Thoracic Oncology (2019)

Evaluated BCL-2/BCL-XL inhibition as a sensitization strategy, advancing translational apoptosis-targeted approaches in mesothelioma.

🏆Awards & Recognition 奖项与荣誉

🏆British Thoracic Oncology Group Clinical Investigator Award
🏆Mesothelioma UK Research Excellence Award
🏆IASLC Merit Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 迪恩·芬内尔 的研究动态

Follow Dean Fennell's research updates

留下邮箱,当我们发布与 Dean Fennell(University of Leicester)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment